Listed pharmaceutical companies’ market capitalization evaporated by KRW 11.64 trillion in 3 months
As the bubble in pharmaceutical and biopharmaceutical stocks has been controversy in the second half of the year, it was observed market capitalizations of domestic listed pharmaceutical companies(including biopharmaceutical and holding companies) have been reduced by more than KRW 11 trillion fo...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
